Artificial Intelligence (AI) Generated "Letters to the Editor" - Helpful Tool or Hidden Hazard? Experience of the PRiMER Journal Written By Dr Jeegar Dattani16 Feb 2026 10:45 AM ISTA recent letter to the editor highlighted that, with artificial intelligence (AI) able to summarise text and draft manuscripts, people can now...
Why Young Medical Researchers Must Struggle! JAMA Warns Against Outsourcing Writing to AI Written By Dr Jeegar Dattani15 Dec 2025 10:30 AM ISTThe fundamental struggle of writing a scientific paper-the effort to describe the choices that articulate meaning-is a vital part of the research...
From Software to Practitioner-Should Artificial Intelligence (AI) Be Licensed Like Clinicians? JAMA November 2025 Published Viewpoint Explains Written By Dr Jeegar Dattani25 Nov 2025 12:00 PM ISTGenerative AI systems are rapidly advancing, rendering existing regulatory frameworks insufficient for overseeing their broad clinical capabilities....
Artificial Intelligence (AI) in Health and Healthcare Explained: Top Highlights from JAMA Summit Written By Dr Jeegar Dattani12 Nov 2025 10:45 AM ISTArtificial intelligence (AI) is set to massively disrupt every aspect of health and health care delivery in the coming years, presenting an...
International Diabetes Federation Releases Diabetes Atlas 11th Edition (2025): Top 10 Key Takeaways from India Written By Dr Jeegar Dattani11 April 2025 12:15 PM ISTDiabetes has emerged as one of the most pressing public health concerns in India. As per the International Diabetes Federation (IDF) Diabetes Atlas...
Elective Peri-Operative Management of Patients on GLP-1, GIP Agonists & SGLT-2 Inhibitors: Multidisciplinary Consensus Released Written By Dr Jeegar Dattani11 Feb 2025 11:34 AM ISTUK: A recent consensus statement from leading UK medical organizations-including the Association of Anaesthetists,the Association of British Clinical...
EVERGREEN Webinar: Clinical FAQs on T2DM Care, Addressed by Dr V Mohan Written By Dr Jeegar Dattani6 March 2024 12:29 PM ISTThe Evergreen webinar addressed the clinical applicability of Linagliptin and Dapagliflozin in real-world clinical scenarios of type 2 diabetes....
Top 10 Messages from Evergreen Webinar on Clinical Applicability of Linagliptin Dapagliflozin in Type 2 Diabetes, Addressed by Dr V Mohan Written By Dr Jeegar Dattani12 Feb 2024 12:15 PM ISTDr. V. Mohan, M.D., FRCP (London, Edinburgh, Glasgow & Ireland), Ph.D., D.Sc. D.Sc (Hon. Causa), FNASc, FASc, FNA, FACE, FACP, FTWAS, MACP, FRSE....
Top Ten US-FDA Approved Pharmacological Agents in 2023: A Year in Review Written By Dr Jeegar Dattani30 Dec 2023 3:51 PM ISTWe come to the end of 2023. Here are top ten pharmacological agents that received US-FDA approval throughout this year, across key therapy areas:1)...
Potassium-Competitive Acid Blockers (P- CABs) for GERD Management - Potential Game Changer or Washout? Written By Dr Jeegar Dattani7 Dec 2023 11:30 AM ISTProton pump Inhibitors have been used globally for the management of gastroesophageal disease (GERD) and Acid Peptic Disease (APD) for a long time....
Lifestyle Interventions in Hypertension: International Society of Hypertension 2023 Position Paper Written By Dr Jeegar Dattani17 Oct 2023 5:52 PM ISTHypertension, defined as persistently elevated systolic blood pressure (SBP) >140mmHg and/or diastolic blood pressure (DBP) at least 90mmHg...
Digital Eye Strain - Shadow Pandemic" in the era of the COVID-19 pandemic Written By Dr Jeegar Dattani7 Nov 2022 9:45 AM ISTA study which is about the "Digital Eye Strain - Shadow Pandemic" in the era of the COVID-19 pandemic" The waves of the COVID-19 pandemic may have...
